Clinical trial
Special Drug Use Investigation of EYLEA for AMD
NCT01756248 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation of EYLEA for AMD
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 26, 2012
- Completion date
- May 20, 2019
- Enrollment
- 3,872 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.